Meet Cromos Pharma’s CEO, Dr. Vlad Bogin in San Antonio, Texas at San Antonio Breast Cancer Symposium (SABCS 2016) on December 6-10, 2016

Cromos™ Pharma helps Regen Biopharma in filing of an Investigational New Drug (IND) application with the FDA

Regen BioPharma announced today filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company’s HemaXellerate I™ stem cell drug in patients with drug-refractory aplastic anemia. Cromos Pharma’s team took active part in IND application preparation.

More details can be found at Regen Biopharma website and press-release.

CONTACT

BD@CROMOSPHARMA.COM

To arrange an introductory meeting and find out how our experience can benefit your next clinical project.

NEWS

EVENTS

Clinical trials in Kazakhstan, cro in Kazakhstan, clinical research organization in Kazakhstan
Clinical Trials in Kazakhstan
Cromos Pharma Expanding in Turkey, Kazakhstan and Serbia countries, clinical trials in Türkiye, clinical trials in Kazakhstan, Clinical trials in Serbia, cro in Türkiye, CRO in Kazakhstan & CRO in Serbia
Cromos Pharma Solidifies Its Operational Presence in Türkiye, Kazakhstan and Serbia
World Lymphoma Awareness Day, wlad, lymphoma clinical trials, lymphoma statistics
World Lymphoma Awareness Day 2022
Remote Monitoring methods in Clinical Trials, using wearables and tracking devices in clinical trails, FDA regulations of wearables in clinical trials
Wearable Devices for Remote Monitoring in Clinical Trials
Clinical Protocol Writing, cromos pharma, clinical study protocol, clinical research protocol, how to write clinical protocol
It all Starts with the Protocol
eConsent in Clinical Trials, electronic informed consent in clinical trials
eConsent and Clinical Trials
Cromos Pharma continues to battle COVID-19, covid 19 clinical trails, clinical trials, contract research organization
Cromos Pharma continues to battle COVID-19
National Immunization Awareness Month August 2022
August is National Immunization Awareness Month- Cromos Pharma
decentralised clinical trials, benefits of decentralised clinical trials, prospects and future of decentralised clinical trials
Decentralized Clinical Trials. What does the future hold?
Cromos Pharma Highlights Psoriasis Awareness and Action Month
Monkeypox was Declared a Global Health Emergency by WHO
Patients’ Portal: New Languages added
Key Takeaways from the BIO International Convention 2022
Key Takeaways from the BIO International Convention 2022
Key Takeaways from ASCO Annual Meeting 2022
patient centricity
Cromos Pharma Committed to Patient Centricity in Clinical Trials
Cromos Pharma's CEO Vlad Bogin's interview at the National Desk, An Unseen Cost of the Ukraine War,
An Unseen Cost of the Ukraine War
Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy Bulgun Margaeva
Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy
Cromos Pharma Names New Country Head in Poland, bozeba sasorska
Cromos Pharma Names New Country Head in Poland
Meet Cromos Pharma at the BIO International Convention 2022
Meet Cromos Pharma at the BIO International Convention 2022
Meet Cromos Pharma at ASCO Annual Meeting 2022, US-based clinical research organisation
Meet Cromos Pharma at ASCO Annual Meeting 2022
Clinical Trials Disrupted During War in Ukraine, Clinical Trials in Ukraine
Clinical Trials Disrupted During War in Ukraine
clinical trials in central & easter europe, Company facts,
Cromos Pharma’s Clinical Research Focus March 2022
US and Europe biosimilars, clinical trials in EU & US
Patient recruitment challenges for clinical trials
clinical trials in central & easter europe, Meet Cromos Pharma at SCOPE 2022,
Key takeaways from Scope 2022
The role of decentralized approaches in clinical trials, clinical trials phases
The role of decentralized approaches in clinical trials
7 steps for successful clinical trial protocol design,
7 steps for successful clinical trial protocol design
European medicines agencies launch public consultation on joint strategy
A new era for clinical trials in Europe
Cromos Pharma launches clinical research focus newsletter
Cromos Pharma launches clinical research focus newsletter
"No Patients - No Payment" risk-sharing program explained
“No Patients – No Payment” risk-sharing program explained
Cromos Pharma on clinical trial trends for 2022,
Cromos Pharma on clinical trial trends for 2022